The veterinary diagnostics market is projected to grow from USD 4.04 billion in 2022 to USD 7.27 billion by 2030, driven by the increasing prevalence of zoonotic diseases and the rising adoption of ...

The "Molecular Diagnostics Patent Landscape Report" report has been added to ResearchAndMarkets.com's offering. The global ...

ABL Diagnostics (FR001400AHX6 – ABLD, the“Company”), a Euronext-listed leader in molecular diagnostics, is pleased to announce an exclusive distribution agreement with Genient Tech Private Ltd. ( ).

A global biotech company is cutting 108 jobs at a Santa Clara branch, according to a notice filed with the state. Roche ...

Discover how Danaher refocuses on life sciences with strong fundamentals and strategic growth, despite near-term challenges.

ABL1 digital PCR can reliably quantify stable deep molecular remission of chronic myeloid leukemia (CML), which will help to ...

Some 2,000 scientists, including dozens of Nobel Prize winners, have signed an open letter warning that the U.S. lead in ...

ABL1 digital PCR can reliably quantify stable deep molecular remission of chronic myeloid leukemia (CML), which will help to determine for which patients chronic drug treatment could potentially be ...

IDEAYA Biosciences, Inc.’s IDYA share price has surged by 10.70%, which has investors questioning if this is right time to sell.

An AI model trained on large amounts of genetic data can predict whether bacteria will become antibiotic-resistant. The new ...